secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025155
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Nephros signs exclusive license & supply deal with Medica; min purchases €4.98M-€6.3M/yr through 2030
--------------------------------------------------------------------------------

- Replaces prior Dec 2023 License & Supply Agreement with Medica; that agreement terminated.
- Nephros receives exclusive right to market & sell Products using Medica's Medisulfone ultrafiltration tech.
- Minimum annual purchases from Medica: €4.976M (2026), €5.349M (2027), €5.750M (2028), €6.000M (2029), €6.300M (2030).
- Term through Dec 31, 2030; Nephros may terminate for convenience with 90 days' notice; Medica may terminate for uncured monetary default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225025155/0001493152-25-025155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225025155/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer